IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP

Watchlist Manager
IOL Chemicals and Pharmaceuticals Ltd Logo
IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
Watchlist
Price: 348.2 INR 1.89% Market Closed
Market Cap: 20.4B INR
Have any thoughts about
IOL Chemicals and Pharmaceuticals Ltd?
Write Note

IOL Chemicals and Pharmaceuticals Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IOL Chemicals and Pharmaceuticals Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
Income from Continuing Operations
â‚ą1.2B
CAGR 3-Years
-32%
CAGR 5-Years
-17%
CAGR 10-Years
41%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Income from Continuing Operations
â‚ą55.7B
CAGR 3-Years
47%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Income from Continuing Operations
â‚ą44.9B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
14%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Income from Continuing Operations
â‚ą111.4B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
5%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Income from Continuing Operations
â‚ą18B
CAGR 3-Years
12%
CAGR 5-Years
27%
CAGR 10-Years
8%
M
Mankind Pharma Ltd
NSE:MANKIND
Income from Continuing Operations
â‚ą19.4B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

IOL Chemicals and Pharmaceuticals Ltd
Glance View

Market Cap
20.4B INR
Industry
Pharmaceuticals

IOL Chemicals & Pharmaceuticals Ltd. engages in the manufacture of organic and inorganic chemical compounds. The company is headquartered in Ludhiana, Punjab and currently employs 2,316 full-time employees. The company went IPO on 2010-11-05. The firm is engaged in manufacturing and selling of organic chemicals, specialty, intermediates, and bulk drugs. Its product portfolio covers various therapeutic categories, such as Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant, amongst others. Its active pharma ingredients (API) product portfolio include Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its specialty chemical division include Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid. The firm caters to the pharmaceutical and specialty chemical requirements across both domestic and international markets. The company serves Austria, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland and others.

IOLCP Intrinsic Value
528.04 INR
Undervaluation 34%
Intrinsic Value
Price

See Also

What is IOL Chemicals and Pharmaceuticals Ltd's Income from Continuing Operations?
Income from Continuing Operations
1.2B INR

Based on the financial report for Jun 30, 2024, IOL Chemicals and Pharmaceuticals Ltd's Income from Continuing Operations amounts to 1.2B INR.

What is IOL Chemicals and Pharmaceuticals Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
41%

Over the last year, the Income from Continuing Operations growth was -21%. The average annual Income from Continuing Operations growth rates for IOL Chemicals and Pharmaceuticals Ltd have been -32% over the past three years , -17% over the past five years , and 41% over the past ten years .

Back to Top